Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma

Published:2019-08-21 Issue:6 Volume:130 Page:1470-1478
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Lehman Christine E.¹,Khalil Ashraf A.¹²,Axelrod Mark J.¹³,Dougherty Michael I.¹^ORCID,Schoeff Stephen S.¹,Taniguchi Linnea E.¹,Mendez Rolando E.¹,David Abel P.¹,McGarey Patrick O.¹,Hubbard Matthew A.¹,Donaldson Lane¹,Frierson Henry F.⁴,Stelow Edward B.⁴,Bekiranov Stefan⁵,Wulfkuhle Julia D.⁶,Petricoin Emanuel F.⁶,Gioeli Daniel G.³,Jameson Mark J.¹^ORCID

Affiliation:

1. Department of Otolaryngology–Head and Neck SurgeryUniversity of Virginia Health System Charlottesville Virginia U.S.A.

2. Department of Biochemistry and Molecular DiagnosticsNational Liver Institute, Menoufiya University Shebin El Kom Egypt

3. Department of Microbiology, Immunology and Cancer BiologyUniversity of Virginia School of Medicine Charlottesville Virginia U.S.A.

4. Department of PathologyUniversity of Virginia Health System Charlottesville Virginia U.S.A.

5. Department of Biochemistry and Molecular GeneticsUniversity of Virginia School of Medicine Charlottesville Virginia U.S.A.

6. Center for Applied Proteomics and Molecular MedicineGeorge Mason University Manassas Virginia U.S.A.

Funder

National Institute of Dental and Craniofacial Research

National Institutes of Health

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.28236

Reference47 articles.

1. Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

2. Cancer Facts & Figures 2018;American Cancer Society;Atlanta, GA: American Cancer Society,2018

3. Chemotherapy advances in locally advanced head and neck cancer

4. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

5. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer;The Applied Biology & Chemistry Journal;2023-03-31

2. Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTNIGF1R;Cancer Research Communications;2023-01-19

3. Oral submucous fibrosis stimulates invasion and epithelial‐mesenchymal transition in oral squamous cell carcinoma by activating MMP‐2 and IGF‐IR;Journal of Cellular and Molecular Medicine;2021-09-15

4. Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma;Cancers;2020-11-29

5. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank;Cancer Epidemiology Biomarkers & Prevention;2020-08-20